Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Class Action
Pharma
Pfizer ponies up $39M to resolve old pay-for-delay lawsuit
Pfizer and a class action group of direct drug purchasers have agreed to settle an antitrust, pay-for-delay claim for $39 million.
Kevin Dunleavy
Apr 11, 2024 11:00am
J&J, IBM face class-action lawsuit over patient data breach
Sep 26, 2023 10:45am
Lawsuits filed over ineffective decongestants
Sep 15, 2023 10:37am
Alexion inks $125M deal to resolve investor lawsuit
Sep 14, 2023 11:41am
Shkreli and co. settle antitrust suit for $28M
Feb 1, 2022 3:40pm
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
Nov 19, 2021 8:20am
